This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

P3 Prostate Cancer Forum: 2024

Session 1 - Prostate Cancer Screening: Current Perspectives on effective management

P3 background - Article

In session 1, explore valuable insights on prostate cancer screening. Our expert panel delve into the changing dynamics within screening in the UK and the EU, including the latest on the TRANSFORM study. 

The session is been split into three sections:

Prostate Cancer Screening: Prostate Cancer UK’s Position, plans and priorities - Dr Matthew Hobbs

Prostate Cancer Screening – a European Model – Prof Phil Cornford

Prostate Cancer Screening in the UK – are we ready for a change? – Professor Caroline Moore


Prostate Cancer Screening: Prostate Cancer UK’s Position, plans and priorities

Dr Matthew Hobbs

P3 Prostate Cancer Forum Meeting Summary 2024

Meeting Summary Downloadable

Download the summary below for the key takeaways from this meeting.

Speakers

P3 Prostate Cancer Forum 2024 - Session 2 Thumbnail

Session 2 - Decoding mHSPC: Unravelling the complexities

In session 2,  our experts share their insights on optimising treatment in mHSPC, delving specifically into triple therapy: data, case studies and holistic patient management. 

Register your interest to P3 2025 now!
Register your interest in attending the P3 2025 meeting
PP-NUB-GB-1919, October 2024
Session 2: Decoding mHSPC: Unravelling the complexities
Our experts share their insights on optimising treatment in mHSPC, delving specifically into triple therapy.
PP-NUB-GB-2016, January 2025

PP-NUB-GB-2013 | January 2025